Unknown

Dataset Information

0

Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs.

ABSTRACT:

SUBMITTER: Zhang Z 

PROVIDER: S-EPMC8382737 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Immunotherapy for Esophageal Squamous Cell Carcinoma.
| S-EPMC5374168 | biostudies-literature
Unknown Immunotherapy for esophageal squamous cell carcinoma: a review.
| S-EPMC6141453 | biostudies-literature
Unknown Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors.
| S-EPMC7081270 | biostudies-literature
Unknown Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer.
| S-EPMC4570139 | biostudies-literature
Unknown Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients.
| S-EPMC5438074 | biostudies-literature
Unknown Smoking affects treatment outcome in patients with resected esophageal squamous cell carcinoma who received chemotherapy.
| S-EPMC4395356 | biostudies-literature
Unknown Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
| S-EPMC8557514 | biostudies-literature
Unknown Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma.
| S-EPMC5220610 | biostudies-literature
Unknown PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
| S-EPMC5058710 | biostudies-literature
Unknown Low GSTM3 expression is associated with poor disease-free survival in resected esophageal squamous cell carcinoma.
| S-EPMC7821639 | biostudies-literature